# OS Therapies Inc: filings

OSTX · NYSE · CIK 1795091 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ostx.md) · [Financials](/companies/ostx/financials.md) · [Filings](/companies/ostx/filings.md) · [Insiders](/companies/ostx/insiders.md)

## Reports and events: 74 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 40, 4 35, CORRESP 31, 3 14, D 13, UPLOAD 10, EFFECT 9, S-1/A 9, 10-Q 8, 5 7, S-1 6, 424B5 4, DEFA14A 4, NT 10-Q 4, SCHEDULE 13D/A 4, 424B7 3, DEF 14A 3, POS AM 3, RW 3, S-8 3, 10-K 2, ARS 2, DRS/A 2, DRSLTR 2, PRE 14A 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 144 1, 3/A 1, 424B3 1, 424B4 1, 4/A 1, 5/A 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, NT 10-K 1, S-3 1, SC 13G 1, SCHEDULE 13D 1, SCHEDULE 13G 1, SP 15D2 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 08:47 ET | [8-K](/filings/0001213900-26-110497.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-110497 |
| 2026-10-05 | 16:37 ET | [8-K](/filings/0001213900-26-106849.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-106849 |
| 2026-09-10 | 17:28 ET | [8-K](/filings/0001213900-26-098880.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-098880 |
| 2026-09-09 | 16:17 ET | [8-K](/filings/0001213900-26-098403.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-098403 |
| 2026-08-21 | 16:50 ET | [8-K](/filings/0001213900-26-092651.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-092651 |
| 2026-08-14 | 17:01 ET | [10-Q](/filings/0001213900-26-090238.md) | Quarterly report, period 2026-06-30 | 0001213900-26-090238 |
| 2026-08-12 | 16:56 ET | [8-K](/filings/0001213900-26-088435.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-088435 |
| 2026-08-06 | 16:13 ET | [8-K](/filings/0001213900-26-086150.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-086150 |
| 2026-07-29 | 17:00 ET | [8-K](/filings/0001213900-26-082876.md) | 1.02 Termination of a material agreement | 0001213900-26-082876 |
| 2026-07-24 | 16:16 ET | [DEF 14A](/filings/0001213900-26-081390.md) | Proxy statement, period 2026-09-09 | 0001213900-26-081390 |
| 2026-07-07 | 09:18 ET | [8-K/A](/filings/0001213900-26-075781.md) | 9.01 Financial statements and exhibits | 0001213900-26-075781 |
| 2026-07-02 | 16:30 ET | [8-K](/filings/0001213900-26-075013.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-075013 |
| 2026-05-18 | 06:02 ET | [10-Q](/filings/0001213900-26-058070.md) | Quarterly report, period 2026-03-31 | 0001213900-26-058070 |
| 2026-04-30 | 16:06 ET | [8-K](/filings/0001213900-26-050211.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-050211 |
| 2026-04-02 | 17:25 ET | [8-K](/filings/0001213900-26-039529.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-039529 |
| 2026-03-31 | 16:20 ET | [8-K](/filings/0001213900-26-037476.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-037476 |
| 2026-03-31 | 20:07 ET | [10-K](/filings/0001213900-26-036629.md) | Annual report, period 2025-12-31 | 0001213900-26-036629 |
| 2026-03-06 | 16:45 ET | [8-K](/filings/0001213900-26-024726.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-024726 |
| 2026-02-13 | 16:06 ET | [8-K](/filings/0001213900-26-016408.md) | 8.01 Other events | 0001213900-26-016408 |
| 2026-01-12 | 08:35 ET | [8-K](/filings/0001213900-26-003166.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-003166 |
| 2025-11-14 | 16:08 ET | [10-Q](/filings/0001213900-25-110829.md) | Quarterly report, period 2025-09-30 | 0001213900-25-110829 |
| 2025-10-21 | 16:16 ET | [8-K](/filings/0001213900-25-100821.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-100821 |
| 2025-10-17 | 17:06 ET | [8-K](/filings/0001213900-25-100019.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-100019 |
| 2025-09-30 | 16:07 ET | [8-K](/filings/0001213900-25-093936.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-093936 |
| 2025-09-02 | 16:28 ET | [8-K](/filings/0001213900-25-083396.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-083396 |
| 2025-08-26 | 06:15 ET | [8-K](/filings/0001213900-25-080484.md) | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-080484 |
| 2025-08-25 | 17:14 ET | [DEF 14A](/filings/0001213900-25-080407.md) | Proxy statement, period 2025-10-14 | 0001213900-25-080407 |
| 2025-08-19 | 06:50 ET | [8-K](/filings/0001213900-25-078152.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-078152 |
| 2025-08-18 | 21:55 ET | [SCHEDULE 13D/A](/filings/0001641172-25-024711.md) | Ownership report, active investor, amended | 0001641172-25-024711 |
| 2025-08-18 | 16:06 ET | [10-Q](/filings/0001213900-25-077916.md) | Quarterly report, period 2025-06-30 | 0001213900-25-077916 |
| 2025-08-15 | 16:05 ET | [8-K](/filings/0001213900-25-077431.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-077431 |
| 2025-08-04 | 16:30 ET | [S-1](/filings/0001213900-25-071368.md) | Registration statement | 0001213900-25-071368 |
| 2025-07-14 | 08:06 ET | [8-K](/filings/0001213900-25-063479.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-063479 |
| 2025-06-27 | 07:59 ET | [8-K](/filings/0001213900-25-058603.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001213900-25-058603 |
| 2025-06-24 | 08:02 ET | [8-K](/filings/0001213900-25-056911.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-056911 |
| 2025-05-23 | 16:51 ET | [S-1](/filings/0001213900-25-047395.md) | Registration statement | 0001213900-25-047395 |
| 2025-05-16 | 16:05 ET | [8-K](/filings/0001213900-25-044875.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-044875 |
| 2025-05-15 | 16:57 ET | [10-Q](/filings/0001213900-25-044336.md) | Quarterly report, period 2025-03-31 | 0001213900-25-044336 |
| 2025-05-09 | 21:30 ET | [SCHEDULE 13D/A](/filings/0001641172-25-009544.md) | Ownership report, active investor, amended | 0001641172-25-009544 |
| 2025-04-15 | 16:05 ET | [8-K](/filings/0001213900-25-032071.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-032071 |
| 2025-04-09 | 17:29 ET | [8-K](/filings/0001213900-25-030375.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-030375 |
| 2025-04-02 | 21:01 ET | [8-K](/filings/0001213900-25-027522.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-027522 |
| 2025-03-31 | 16:39 ET | [8-K](/filings/0001213900-25-026322.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-026322 |
| 2025-03-31 | 16:05 ET | [10-K](/filings/0001213900-25-026238.md) | Annual report, period 2024-12-31 | 0001213900-25-026238 |
| 2025-03-12 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001493152-25-010056.md) | Ownership report, active investor, amended | 0001493152-25-010056 |
| 2025-02-28 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001493152-25-008696.md) | Ownership report, active investor, amended | 0001493152-25-008696 |
| 2025-02-28 | 16:05 ET | [DEF 14A](/filings/0001213900-25-018759.md) | Proxy statement, period 2025-03-31 | 0001213900-25-018759 |
| 2025-01-31 | 16:22 ET | [S-1](/filings/0001213900-25-008855.md) | Registration statement | 0001213900-25-008855 |
| 2025-01-29 | 09:27 ET | [8-K](/filings/0001213900-25-007705.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-007705 |
| 2025-01-17 | 19:47 ET | [SCHEDULE 13D](/filings/0001493152-25-002859.md) | Ownership report, active investor | 0001493152-25-002859 |

Page 1 of 2. [Older](/companies/ostx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 21:01 ET. No prices; not investment advice.